- The Effect of Metformin on Antipsychotic-induced Weight Gain in Patients with Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
-
Sin HY, Chun P
- KMID: 2438546
- Korean J Clin Pharm.
- 2018 Sep;28(3):204-215.
- doi: 10.24304/kjcp.2018.28.3.204
BACKGROUND: In this systematic review and meta-analysis, the effect of metformin on weight loss was assessed to determine whether metformin should be recommended for the prevention or treatment of weight... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Analysis of Ethical-the-counter Drugs and Over-the-counter Drugs for the Adverse Events from the Community Pharmacy
-
Lee MS, Park SH, Kim NY, Oh IS, Lee JM, Lee EK, Shin JY
- KMID: 2438549
- Korean J Clin Pharm.
- 2018 Sep;28(3):230-237.
- doi: 10.24304/kjcp.2018.28.3.230
OBJECTIVE: To compare adverse event reporting patterns between ethical-the-counter and over-the-counter drugs from community pharmacies and outpatient settings. METHODS: We conducted a descriptive study using the adverse event reporting database, wherein... -
- CITED
-
- Close
- SHARE
-
- Close
- A Review on Efficacy and Safety of SGLT2 Inhibitors as Add-on Therapy with Metformin
-
Jeong KH
- KMID: 2438551
- Korean J Clin Pharm.
- 2018 Sep;28(3):243-249.
- doi: 10.24304/kjcp.2018.28.3.243
BACKGROUND: The new type of diabetes treatment, SGLT2 inhibitors, has been approved for monotherapy and combination therapy, but medical insurance is only allowed in combination therapy with metformin, which is... -
- CITED
-
- Close
- SHARE
-
- Close
- Mediation Effect of Self-efficacy between Health Status and Drug Abuse Behavior
-
Park KL, Jang HY
- KMID: 2438550
- Korean J Clin Pharm.
- 2018 Sep;28(3):238-242.
- doi: 10.24304/kjcp.2018.28.3.238
BACKGROUND: The appropriate use of drugs is very important for a healthy life, as appropriate medication must be taken correctly for successful treatment of a disease. The purpose of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Antiemetic Therapy for Breakthrough Nausea and Vomiting in Patients with Hematopoietic Stem Cell Transplantation
-
Kim J, Hong SY, Jeon SJ, Namgung HW, Lee ES, Lee E, Bang SM
- KMID: 2438548
- Korean J Clin Pharm.
- 2018 Sep;28(3):224-229.
- doi: 10.24304/kjcp.2018.28.3.224
BACKGROUND: The patients receiving hematopoietic stem cell transplantation (HSCT) are known to have a high incidence of breakthrough nausea and vomiting due to the conditioning regimen. The purpose of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Bleeding after Taking Dual Antiplatelets and NSAID Concurrently
-
Seo J, Choi J, Son P, Lee S, Chae H, Kang G, Ji E
- KMID: 2438552
- Korean J Clin Pharm.
- 2018 Sep;28(3):250-253.
- doi: 10.24304/kjcp.2018.28.3.250
When stenting is applied to treat myocardial infarction, antiplatelet agents are administered to prevent thrombosis, which increases the risk of bleeding. Patients with myocardial infarction are also more likely to... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Use Evaluation of Clostridium difficile Infection in Elderly Patients and Risk Factors of Non-improving Group
-
Noh HJ, Ham JY, Lee JG, Rhie SJ
- KMID: 2438542
- Korean J Clin Pharm.
- 2018 Sep;28(3):174-180.
- doi: 10.24304/kjcp.2018.28.3.174
OBJECTIVE: Clostridium difficile Infection (CDI) is one of the common nosocomial infections. As elderly population increases, the proper treatment has been emphasized. We investigated the risk factors associated with CDI... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns and Persistence of Pharmacotherapy for Children and Adolescents with Attention Deficit Hyperactivity Disorder in South Korea
-
Lee KE, Je NK
- KMID: 2438547
- Korean J Clin Pharm.
- 2018 Sep;28(3):216-223.
- doi: 10.24304/kjcp.2018.28.3.216
OBJECTIVE: This study aimed to assess treatment persistence in Korean children and adolescents with attention deficit hyperactivity disorder (ADHD) and the factors influencing their adherence to ADHD pharmacotherapy. METHODS: The study... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent Use of Sulfonylureas and Antimicrobials of the Elderly in Korea: A Potential Risk of Hypoglycemia
-
Lee S, Ock M, Kim H
- KMID: 2438544
- Korean J Clin Pharm.
- 2018 Sep;28(3):188-193.
- doi: 10.24304/kjcp.2018.28.3.188
BACKGROUND: Previous studies have noted that the simultaneous use of sulfonylureas and antimicrobials, which is common, could increase the risk of hypoglycemia. In particular, an age of 65 years or... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Fracture Prevalence and Glycemic Control in Korean Older and Middle-aged Patients with Diabetes: A Retrospective Analysis of a Cohort Derived from the Korean National Health Insurance Sharing Service Database, 2009–2013
-
Sin HY
- KMID: 2438545
- Korean J Clin Pharm.
- 2018 Sep;28(3):194-203.
- doi: 10.24304/kjcp.2018.28.3.194
BACKGROUND: Bone fractures are high in elderly patients with type 2 diabetes mellitus (T2DM). Hyperglycemia and chronic kidney disease may increase the risk of fracture prevalence via altered bone metabolism,... -
- CITED
-
- Close
- SHARE
-
- Close
- Posaconazole for Prophylaxis of Fungal Infection in Pediatric Patients with Acute Myeloid Leukemia undergoing Induction Chemotherapy
-
Kim SM, Ree YS, Kim JS, Kim SH, Son ES, Lyu CJ
- KMID: 2438543
- Korean J Clin Pharm.
- 2018 Sep;28(3):181-187.
- doi: 10.24304/kjcp.2018.28.3.181
BACKGROUND: Posaconazole is a broad-spectrum triazole antifungal agent and the most recommended prophylactic antifungal agent for patients with acute myeloid leukemia (AML) undergoing induction chemotherapy. In this study, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Piperacillin/Tazobactam Dosing (13.5 g/day vs. 18 g/day) for the Treatment of Hospital-Acquired Pneumonia and Ventilator-associated Pneumonia in Intensive Care Unit
-
Kang JY, Lee KA, Kim JS, Kim SH, Son ES
- KMID: 2438541
- Korean J Clin Pharm.
- 2018 Sep;28(3):167-173.
- doi: 10.24304/kjcp.2018.28.3.167
BACKGROUND: In July 2016, the Infectious diseases society of america and the american thoracic society (IDSA & ATS) published a guideline recommending piperacillin/tazobactam (Pip/Tazo) 18 g/day as the anti-pseudomonal dose... -
- CITED
-
- Close
- SHARE
-
- Close
